“Aankoop en export van geneesmiddelen en farmaco-medisch materiaal, voedingssupplementen en cosmetica” (deed in Dutch)
From the articles, 9 activitiesNo NACE code in the KBO yet
Size
€2.4mtotal assets 2024
Equity
€2.0m
Profit
€739,724
Financial health
Inactive: no score
Structure
Holdings
3
3 of 13 deeds summarised
Signalsraises risk2024 accounts filed 29 days lateShow the evidence
Signals
1 signal.
raises risk
raises risk · 2024 accounts filed 29 days late
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-08-2025, 29 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
This company filed its last 7 accounts on average 16 days after the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
Restructuring · End & cessationMerger · Dissolution · Power…